keine Finanzberatung

WAT · Waters Corporation

Analytical lab instruments — chromatography and mass spec, newly combined with BD's diagnostics arm

Risiko 5/10 · MODERATE RISK · merger-integration play · $409.38 ▼ 1.01%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $409.38
  • Market cap $40.2B
  • P/E (ttm) 104.17
  • Div yield none
  • 52-wk range $282.77 – $426.22
  • Index rank #278 / —

Wichtigste Risiken

  • Integration of BD's diagnostics unit disappoints (Shareholders) — HIGH
  • Pharma capex and China demand cycles (Shareholders) — MED
  • Deal debt taken on to close the combination (Bondholders) — MED
  • Customer attrition and dis-synergies in the merged portfolio (Shareholders) — MED

Fazit

Quality franchise, but the next year is an integration story, not an instruments story.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.